ReviewWiley interdisciplinary reviews. RNA
Beyond the Poly(A) Tail: The Expanding Functional Landscape of PABPN1 and Its Dysregulation in OPMD and Cancer.
Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the Poly(A) Tail: The Expanding Functional Landscape of PABPN1 and Its Dysregulation in OPMD and Cancer.Wiley interdisciplinary reviews. RNAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Nuclear poly(A)-binding protein N1 (PABPN1) is a poly(A)-binding protein widely expressed in the nuclei of eukaryotic cells. As a key regulator of mRNA 3'-end processing, it participates not only in poly(A) tail synthesis and length regulation but also in alternative polyadenylation (APA). Recent studies have demonstrated that PABPN1 undergoes liquid-liquid phase separation (LLPS) to form dynamic membraneless compartments, such as nuclear speckles and nuclear poly(A) domains (NPADs), and contributes to its physiological functions. Emerging evidence has further implicated PABPN1 in a range of cellular processes. These include downstream consequences of APA dysregulation, such as altered stress responses and cell fate decisions, as well as APA-independent molecular functions, including its direct roles in DNA repair and cell cycle control. Dysregulation of PABPN1 LLPS, driven either by intrinsic expansion of its N-terminal alanine stretch or by altered interactions with regulatory cofactors, promotes a transition from dynamic liquid-like condensates to pathological solid-like aggregates. This phase transition is associated with the pathogenesis of oculopharyngeal muscular dystrophy (OPMD) and contributes to oncogenic APA patterns in various cancers. This review summarizes recent findings on the emerging physiological functions of PABPN1, its phase separation characteristics, and the molecular mechanisms underlying its transition into pathological aggregates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.